Summary
Ryan Bloom is an accomplished corporate development leader with 11 years of experience translating deep scientific training (PhD in Bioengineering from Stanford) into high-impact business outcomes across cell and gene therapy and immuno-oncology. He has led BD, strategy, and new product planning through senior roles at Superluminal Medicines and BlueRock, executing complex transactions, alliances, and capital-raising including IPO-related work. Known for pairing rigorous analytical problem-solving with hands-on program and portfolio planning, he moves fluidly between scientific detail and commercial strategy. Ryan’s career includes founding a biotech, leading immuno-oncology product commercialization, and steering M&A and in-licensing, reflecting an uncommon blend of entrepreneurship and institutional deal experience. Based in Belmont, MA, he brings a track record of turning advanced modalities into actionable partnerships and pipeline value.
11 years of coding experience
8 years of employment as a software developer
Johns Hopkins University
PhD Bioengineering, PhD Bioengineering at Stanford University